Taiga Treats First Cancer Patient in TBX-3400-003 Clinical Trial in Israel
AURORA, Colo. & PETACH TIQWA, Israel–(BUSINESS WIRE)–Taiga Biotechnologies, a cell-based immunotherapy company, announced today that a colorectal cancer patient at…
Pharmaceuticals, Biotechnology and Life Sciences
AURORA, Colo. & PETACH TIQWA, Israel–(BUSINESS WIRE)–Taiga Biotechnologies, a cell-based immunotherapy company, announced today that a colorectal cancer patient at…
AURORA, Colo. & PETACH TIQWA, Israel–(BUSINESS WIRE)–Taiga Biotechnologies, a cell-based immunotherapy company, announced today that a colorectal cancer patient at…
– 11 New Partner Programs Entered Clinical Development in 2020 – – Total of 43 Clinical Programs Initiated to Date…
Study evaluating engineered FGF-1’s (TTHX114) potential in patients undergoing Descemet Stripping Only (DSO or DWEK) procedures SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics…
AURORA, Colo. & PETACH TIQWA, Israel–(BUSINESS WIRE)–Taiga Biotechnologies, a cell-based immunotherapy company, announced today that a colorectal cancer patient at…
BROOKLYN, N.Y.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: BROOKLYN…
BROOKLYN, N.Y.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: BROOKLYN…
BROOKLYN, N.Y.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: BROOKLYN…
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical,…
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical,…